Commission Regulation (EU) 2017/171 amending Annexes II, III and IV to Regulation (EC) No. 396/2005 of the European Parliament and of the Council as regards maximum residue levels for aminopyralid, azoxystrobin, cyantraniliprole, cyflufenamid, cyproconazole, diethofencarb, dithiocarbamates, fluazifop-P, fluopyram, haloxyfop, isofetamid, metalaxyl, prohexadione, propaquizafop, pyrimethanil, Trichoderma atroviride strain SC1 and zoxamide in or on certain products.
Country
Type of law
Legislation
Abstract
This Regulation amends Annexes II, III and IV to Regulation (EC) No. 396/2005 as regards maximum residue levels applicable to aminopyralid, azoxystrobin, cyantraniliprole, cyflufenamid, cyproconazole, diethofencarb, dithiocarbamates, fluazifop-P, fluopyram, haloxyfop, isofetamid, metalaxyl, prohexadione, propaquizafop, pyrimethanil, Trichoderma atroviride strain SC1 and zoxamide in or on certain products.
Attached files
Date of text
Repealed
No
Serial Imprint
Official Journal of the European Union L 30, 3 February 2017, pp. 45-111.
Source language
English
Legislation status
in force
Legislation Amendment
No